ID 405110776 · FY 2020–2024 · 5 years
კომპანიის ძირითად საქმიანობას წარმოადგენს ვაჭრობა სამედიცინო აპარატურით და ინსტრუმენტებით, ასევე სამედიცინო აპარატურის შეკეთება და მონტაჟი.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Ratio | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 45.3% | 38.4% | 39.3% | 37.9% | 47.2% |
| EBITDA Margin | 36.9% | 27.6% | 25.9% | 25.6% | 27.5% |
| EBITDAR | 1,125 | 1,336 | 1,562 | 1,941 | 1,195 |
| EBITDAR Margin | 37.3% | 27.6% | 25.9% | 25.6% | 27.5% |
| EBIT Margin | 36.5% | 26.9% | 25.0% | 24.9% | 26.2% |
| Net Profit Margin | 36.4% | 26.4% | 23.9% | 24.2% | 26.2% |
| Operating Expense % of Sales | 8.4% | 10.7% | 13.4% | 12.2% | 19.7% |
| Returns | |||||
| Return on Assets (ROA) | 47.1% | 37.0% | 29.9% | 27.6% | 14.1% |
| Return on Equity (ROE) | 53.0% | 39.5% | 30.9% | 28.1% | 14.9% |
| ROIC [EBIT / Invested Capital] | 52.1% | 45.0% | 33.0% | 31.4% | 16.4% |
| Leverage & liquidity | |||||
| Debt-to-Assets | 3.8% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.04x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.08x | 0.00x | 0.00x | 0.00x | 0.00x |
| Equity-to-Assets | 88.8% | 93.7% | 96.9% | 98.3% | 94.7% |
| Net Debt | 43 | -342 | -117 | -494 | -711 |
| Cash & Equivalents | 46 | 342 | 117 | 494 | 711 |
| Total Debt | 89 | N/A | N/A | N/A | N/A |
| Efficiency & working capital | |||||
| Inventory Turnover | 2.33x | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | 156.7 | N/A | N/A | N/A | N/A |
| Receivables Turnover | 3.57x | 8.99x | 7.05x | 6.31x | 3.58x |
| Days Sales Outstanding (DSO) | 102.2 | 40.6 | 51.8 | 57.8 | 101.8 |
| Payables Turnover | 12.36x | 51.67x | 59.04x | 146.00x | 41.68x |
| Days Payable Outstanding (DPO) | 29.5 | 7.1 | 6.2 | 2.5 | 8.8 |
| Cash Conversion Cycle | 229.4 days | 33.5 days | 45.6 days | 55.3 days | 93.1 days |
| Asset Turnover | 1.29x | 1.40x | 1.25x | 1.14x | 0.54x |
| Cash flow & dividends | |||||
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | N/A | N/A | N/A | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
Ownership & directors from companyinfo.ge (public corporate registry).